-
1
“De Novo” Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature
Published 2023-09-01Subjects: Get full text
Article -
2
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
Published 2023-08-01Subjects: Get full text
Article -
3
-
4
Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice
Published 2023-12-01Subjects: “…Generalized pustular psoriasis…”
Get full text
Article -
5
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study
Published 2023-03-01Subjects: Get full text
Article -
6
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Published 2023-05-01Subjects: Get full text
Article -
7
Severe Generalized Pustular Psoriasis Successfully Treated with Ixekizumab: A Case Report
Published 2022-11-01Subjects: “…psoriasis…”
Get full text
Article -
8
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study
Published 2022-05-01Subjects: Get full text
Article -
9
A survey of psoriasis patients on biologics during COVID-19: a single centre experience
Published 2022-01-01Get full text
Article -
10
-
11
Real-world use of dimehtyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
Published 2022-12-01Subjects: “…psoriasis treatment…”
Get full text
Article -
12
Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
Published 2023-03-01Subjects: Get full text
Article -
13
Risankizumab: Daily Practice Experience of High Need Patients
Published 2023-06-01Subjects: “…psoriasis…”
Get full text
Article -
14
Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a ‘perceived satisfaction’: a multicentric study
Published 2022-01-01Subjects: Get full text
Article -
15
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis
Published 2020-09-01Subjects: “…psoriasis…”
Get full text
Article -
16
-
17
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
Published 2023-12-01Subjects: “…psoriasis…”
Get full text
Article -
18
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing
Published 2022-05-01Subjects: “…psoriasis…”
Get full text
Article -
19
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)
Published 2024-01-01Subjects: “…psoriasis…”
Get full text
Article -
20
Peristomal Skin Complications: Detailed Analysis of a Web-Based Survey and Predictive Risk Factors
Published 2023-06-01“…The most frequent PSCs observed were dermatitis and pruritis/xerosis in approximately 60% of patients. Psoriasis was strongly correlated with dermatitis, while being overweight or obese increased the risk of pruritis/xerosis. …”
Get full text
Article